<DOC>
	<DOCNO>NCT01161615</DOCNO>
	<brief_summary>A Randomized , Multi-Center , Double-Blind , Placebo-Controlled Phase III Trial Evaluate Efficacy , Tolerability Safety MRX-7EAT Etodolac-Lidocaine Topical Patch Treatment Tendonitis Bursitis Shoulder .</brief_summary>
	<brief_title>MRX-7EAT Etodolac-Lidocaine Topical Patch Treatment Tendonitis Bursitis Shoulder</brief_title>
	<detailed_description />
	<mesh_term>Tendinopathy</mesh_term>
	<mesh_term>Bursitis</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Etodolac</mesh_term>
	<criteria>Main Subject 14 year age old ( assent accord state law ) . Females child bear potential must negative pregnancy test . Subject diagnosis acute tendonitis bursitis one shoulder onset current episode 5 day ≤ 21 day precede screen visit . Diagnosis indicate positive Hawkins Test Neer Test , result pain motion existence shoulder impingement relate tendonitis bursitis . Subject Current Pain Intensity rat prior study entry ≥ 5 ≤ 8 Numeric Pain Rating Scale ( NPRS ) ( 11 point ; range 0 10 ; anchor `` none '' `` severe '' ) . Main Subject suspect tear rotator cuff , calcific tendonitis . Standard Care ( SOC ) diagnosis AP lateral xray , adhesive capsulitis , shoulder fracture , bilateral tendonitis bursitis shoulder ; orthopedic surgical treatment require . Subject positive Drop Arm Test indicative suspect tear ; positive O'Brien 's Test suggestive glenoid labral tear ; positive Apprehension Test would indicative glenohumeral instability . Subject previous episode shoulder pain area within two month . Subject receive passive physical therapy treatment ( e.g. , deep heat ultrasound ) tendonitis/bursitis target shoulder within past 24 hour ; require continue use immobilization device treatment current episode tendonitis bursitis use iontophoresis . Subject use oral pharmacologic treatment ( NSAIDs analgesic medication ) less 3 halflives baseline assessment ; ibuprofen permit prior baseline long within 6 hour baseline assessment . Subject use form opioid within 24 hour study entry use opioids 5 consecutive day within 30 day precede enrollment . Subject receive systemic corticosteroid 30 day precede screen visit . Subject recently initiate sleep medication , muscle relaxant , anticonvulsant antidepressant . Subject use TNF alpha blocker Class 1 antiarrhythmic drug within past 60 day . Subject history physical assessment find clinically significant . GI ulcer abnormal bleeding , anemia , kidney disease , liver disease , poorly control lung , stomach , heart , vital organ disease determine study investigator/physician . Subject history physical assessment find compatible safe participation study . Subject pain medical problem investigator 's opinion may interfere pain measurement target joint . Subject active skin lesion disease intend site application study medication . Subject history allergy etodolac , NSAIDs , lidocaine adhesive ( e.g. , adhesive tape ) . Subject history prior fail treatment topical NSAIDs . Subject history drug alcohol abuse . Subject receive investigational drug within period 30 day prior receive study medication . Subject schedule elective surgery invasive procedure period study participation . Subject workman 's compensation pending legal hearing .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>tendonitis and/or bursitis shoulder</keyword>
	<keyword>acute tendonitis and/or bursitis shoulder</keyword>
</DOC>